Found: 81
Select item for more details and to access through your institution.
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2417377, doi. 10.1001/jamanetworkopen.2024.17377
- By:
- Publication type:
- Article
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e249744, doi. 10.1001/jamanetworkopen.2024.9744
- By:
- Publication type:
- Article
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment.
- Published in:
- JAMA Psychiatry, 2024, v. 81, n. 1, p. 45, doi. 10.1001/jamapsychiatry.2023.3596
- By:
- Publication type:
- Article
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder.
- Published in:
- American Journal on Addictions, 2023, v. 32, n. 6, p. 584, doi. 10.1111/ajad.13463
- By:
- Publication type:
- Article
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR<sub>16</sub>) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial.
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 1443, doi. 10.2147/NDT.S406909
- By:
- Publication type:
- Article
Optimally Choosing Medication Type for Patients With Opioid Use Disorder.
- Published in:
- American Journal of Epidemiology, 2023, v. 192, n. 5, p. 748, doi. 10.1093/aje/kwac217
- By:
- Publication type:
- Article
Rudolph et al. Respond to "Mathematization of Epidemiology".
- Published in:
- American Journal of Epidemiology, 2023, v. 192, n. 5, p. 760, doi. 10.1093/aje/kwad023
- By:
- Publication type:
- Article
Impacts of the New York State COVID‐19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder.
- Published in:
- Addiction, 2023, v. 118, n. 4, p. 711, doi. 10.1111/add.16087
- By:
- Publication type:
- Article
Support for COVID-19-Related Substance Use Services Policy Changes: a New York State-Wide Survey.
- Published in:
- Journal of Behavioral Health Services & Research, 2022, v. 49, n. 3, p. 262, doi. 10.1007/s11414-021-09784-y
- By:
- Publication type:
- Article
Correction to: Support for COVID-19-Related Substance Use Services Policy Changes: a New York State-Wide Survey.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse.
- Published in:
- Addiction, 2022, v. 117, n. 3, p. 637, doi. 10.1111/add.15654
- By:
- Publication type:
- Article
Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.
- Published in:
- Addiction Science & Clinical Practice, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13722-022-00286-6
- By:
- Publication type:
- Article
Cost‐effectiveness implications of increasing the efficiency of the extended‐release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.
- Published in:
- Addiction, 2021, v. 116, n. 12, p. 3444, doi. 10.1111/add.15531
- By:
- Publication type:
- Article
The utility of a formative one‐station objective structured clinical examination for Substance use disorders in a dental curriculum.
- Published in:
- European Journal of Dental Education, 2021, v. 25, n. 4, p. 813, doi. 10.1111/eje.12661
- By:
- Publication type:
- Article
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables.
- Published in:
- Addiction, 2021, v. 116, n. 8, p. 2094, doi. 10.1111/add.15377
- By:
- Publication type:
- Article
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
- Published in:
- Addiction Science & Clinical Practice, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13722-021-00223-z
- By:
- Publication type:
- Article
Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum.
- Published in:
- Advances in Medical Education & Practice, 2020, v. 11, p. 455, doi. 10.2147/AMEP.S251391
- By:
- Publication type:
- Article
Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism.
- Published in:
- Addiction, 2020, v. 115, n. 2, p. 239, doi. 10.1111/add.14735
- By:
- Publication type:
- Article
Commentary on Stein et al. (2020): Whither detoxification in the face of the opioid epidemic?
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Differential Posttreatment Outcomes of Methylphenidate for Smoking Cessation for Individuals With ADHD.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder.
- Published in:
- Addiction, 2019, v. 114, n. 8, p. 1416, doi. 10.1111/add.14636
- By:
- Publication type:
- Article
Buprenorphine Treatment for Opioid Use Disorder: An Overview.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.
- Published in:
- Annals of Internal Medicine, 2019, v. 170, n. 2, p. 90, doi. 10.7326/M18-0227
- By:
- Publication type:
- Article
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.
- Published in:
- Addiction, 2017, v. 112, n. 8, p. 1440, doi. 10.1111/add.13807
- By:
- Publication type:
- Article
Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders.
- Published in:
- 2017
- By:
- Publication type:
- journal article
New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.
- Published in:
- American Journal on Addictions, 2015, v. 24, n. 4, p. 348, doi. 10.1111/ajad.12193
- By:
- Publication type:
- Article
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder.
- Published in:
- JAMA Psychiatry, 2015, v. 72, n. 6, p. 593, doi. 10.1001/jamapsychiatry.2015.41
- By:
- Publication type:
- Article
Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Commentary on Zhou et al. (2015): Treating psychiatric comorbidity in adolescents-an important problem.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Clinically relevant characteristics associated with early treatment drug use versus abstinence.
- Published in:
- Addiction Science & Clinical Practice, 2014, v. 9, p. 1, doi. 10.1186/1940-0640-9-6
- By:
- Publication type:
- Article
Dysregulation of Diurnal Cortisol Secretion Affects Abstinence Induction during a Lead-in Period of a Clinical Trial for Depressed Cocaine-Dependent Patients.
- Published in:
- American Journal on Addictions, 2014, v. 23, n. 1, p. 1, doi. 10.1111/j.1521-0391.2013.12060.x
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients.
- Published in:
- American Journal on Addictions, 2014, v. 23, n. 1, p. 68, doi. 10.1111/j.1521-0391.2013.12065.x
- By:
- Publication type:
- Article
Gabapentin: a new addition to the armamentarium for alcohol dependence?
- Published in:
- 2014
- By:
- Publication type:
- journal article
Gabapentin.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 1, p. 78, doi. 10.1001/jamainternmed.2013.11973
- By:
- Publication type:
- Article
Injectable extended-release naltrexone ( XR- NTX) for opioid dependence: long-term safety and effectiveness.
- Published in:
- Addiction, 2013, v. 108, n. 9, p. 1628, doi. 10.1111/add.12208
- By:
- Publication type:
- Article
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.
- Published in:
- Addiction, 2013, v. 108, n. 6, p. 1084, doi. 10.1111/add.12108
- By:
- Publication type:
- Article
Do Manualized Psychosocial Interventions Help Reduce Relapse among Alcohol-Dependent Adults Treated with Naltrexone or Placebo? A Meta-analysis.
- Published in:
- American Journal on Addictions, 2012, v. 21, n. 6, p. 501, doi. 10.1111/j.1521-0391.2012.00270.x
- By:
- Publication type:
- Article
Implications of Epidemiological Data for Identifying Persons with Substance Use and Other Mental Disorders.
- Published in:
- American Journal on Addictions, 2012, v. 21, n. 2, p. 97, doi. 10.1111/j.1521-0391.2011.00198.x
- By:
- Publication type:
- Article